Emanuela Onesti

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery

Udi Vazana, Ronel Veksler, Gaby S. Pell et al. · Journal of Neuroscience · 2016 · 192 citations · Full text

Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial

Valentina Tomassini, Carlo Pozzilli, Emanuela Onesti et al. · Journal of the Neurological Sciences · 2003 · 165 citations

Fatigue Management, Crossover Trial, Rehabilitation +3

Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis

Francesco Patti, Carlo Pozzilli, E. Montanari et al. · Multiple Sclerosis Journal · 2007 · 134 citations

Dysphagia in Amyotrophic Lateral Sclerosis: Impact on Patient Behavior, Diet Adaptation, and Riluzole Management

Emanuela Onesti, Ilenia Schettino, Maria Cristina Gori et al. · Frontiers in Neurology · 2017 · 112 citations · Full text